Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.64 |
| ▸ | PPARA | Q07869 | 5/20 | 0.64 |
| ▸ | PPARD | Q03181 | 2/20 | 0.64 |
| ▸ | ULK1 | O75385 | 1/20 | 0.48 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | PLK1 | P53350 | 1/20 | 0.37 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gsk-9578 SCHEMBL68327 | 0.78 | PPARG (1.00) | PPARGPPARAPPARDSOAT1 | |
| SCHEMBL20280514 | 0.78 | PPARG (1.00) | PPARGPPARAPPARDSOAT1 | |
| Gsk-9578 SCHEMBL30475595 | 0.78 | PPARG (1.00) | PPARGPPARAPPARDSOAT1 | |
| SCHEMBL2786217 | 0.76 | PPARG (0.59) | PPARGPPARAPPARDULK1RAB9A | |
| SCHEMBL16521916 | 0.71 | PPARG (0.87) | PPARGPPARAPPARDSOAT1 | |
| SCHEMBL6552204 | 0.71 | PPARG (0.81) | PPARGPPARAPPARDSOAT1 | |
| SCHEMBL17471275 | 0.70 | PPARG (0.85) | PPARGPPARAPPARDSOAT1 | |
| SCHEMBL6356255 | 0.69 | PPARG (0.82) | PPARGPPARAPPARDSOAT1 | |
| SCHEMBL6545314 | 0.69 | PPARG (0.82) | PPARGPPARAPPARDSOAT1 | |
| SCHEMBL6334752 | 0.67 | PPARG (0.53) | PPARGPPARAPPARDRAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014015318-A1 | SOLUBLE COMPOUNDS FOR IMPROVED GENE THERAPY METHODS | BLUEBIRD BIO, INC. (US) | 2014-01-23 | — | — | WO | claimed |
| US-20100240627-A1 | COMPOSITION AND METHODS RELATING TO GLUCOCORTICOID RECEPTOR-ALPHA AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS | UNIVERSITEIT GENT | 2010-09-23 | — | — | US | claimed |
| US-20090111782-A1 | COMPOSITION AND METHODS RELATING TO GLUCOCORTICOID RECEPTOR-ALPHA AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS | GHENT UNIVERSITY (BE) | 2009-04-30 | — | — | US | claimed |
| US-20110300129-A1 | SYSTEMS AND METHODS FOR ENHANCING VACCINE EFFICACY | UNIVERSITY OF ROCHESTER (US) | 2011-12-08 | — | — | US | disclosed |
| US-20100240627-A1 | COMPOSITION AND METHODS RELATING TO GLUCOCORTICOID RECEPTOR-ALPHA AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS | UNIVERSITEIT GENT | 2010-09-23 | — | — | US | disclosed |
| US-20090111782-A1 | COMPOSITION AND METHODS RELATING TO GLUCOCORTICOID RECEPTOR-ALPHA AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS | GHENT UNIVERSITY (BE) | 2009-04-30 | — | — | US | disclosed |